aod9604 peptide fat loss evidence clinical trials AOD-9604 Safety Profile: What Show Peptide Therapy for Fat Loss

Preventing Denials: Pre-Authorization and Frequency Limits Certain drugs, especially off-label meds or biologics, may require pre-authorization

Not everyone needs these treatments and thats perfectly okay

### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**

We don't sell compounds off a shelf

Without a dedicated J-code, there is no universal standard, making payer-specific verification essential

All graphs are represented as mean SEM